Clinical Trial Update: Effectiveness of Adalimumab in Moderate to Severe Plaque Psoriasis Patients With Distinct Co-morbidities

View source ↗

Summary

A completed clinical trial investigated the effectiveness of adalimumab in adults with moderate to severe plaque psoriasis, including patients with distinct com…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Plaque Psoriasis

Drugs mentioned

• ADALIMUMAB (ADALIMUMAB-AATY)

Snippet

Sponsor: AbbVie (prior sponsor, Abbott) | Conditions: Moderate to Severe Plaque Psoriasis | Status: COMPLETED | Results posted: 2017-10-04